Profile
| Metric | Value |
|---|---|
| Full Name | Anavex Life Sciences Corp. |
| Ticker | NASDAQ: AVXL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | anavex.com |
| Employees | 42 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.64 | |
| Price, 1D Change | +8.16% | |
| Market Cap | $415M | |
| - | ||
| PE Ratio | - | |
| Beta | 1.15 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$0.54 | |
| EPS, 1Y Change | -5.55% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.54 | |
| EPS Estimate | N/A | -$0.48 |
| EPS Est. Change | N/A | +11.73% |
| Revenue | $0.00 | |
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $4.64 | |
| Price Target | - | $22.00 |
| Price Tgt. Change | - | +374.14% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.55 | -$0.52 | +6.33% | |
| -$0.58 | -$0.54 | +5.70% | |
| -$0.48 | N/A | +11.73% | |
| $1.27 | N/A | +333.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $222.04M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -56.02% | |
| Price, 3Y | -56.14% | |
| Market Cap, 1Y | -53.76% | |
| Market Cap, 3Y | -49.78% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -5.55% | |
| EPS, 3Y | +12.82% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.64 | |
| SMA 200 | $8.10 | |
| SMA 200 vs Price | +74.67% | |
| SMA 50 | $4.53 | |
| SMA 50 vs Price | -2.30% | |
| Beta | 1.15 | |
| ATR | $0.33 | |
| 14-Day RSI | 61.24 | |
| 10-Day Volatility | 64.95% | |
| 1-Year Volatility | 81.51% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$0.54 | |
| Gross Profit | $0.00 | |
| - | ||
| Operating Profit | -$51.41M | |
| - | ||
| Net Income | -$46.38M | |
| - | ||
| EBITDA | -$51.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| 11.60 | ||
| 11.60 | ||
| - | ||
| - | ||
| 22.11 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 4.37 | ||
| -6.07 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $94.87M | |
| $102.58M | ||
| $103.82M | ||
| $103.82M | ||
| $8.95M | ||
| $8.95M | ||
| Total Debt | $0.00 | |
| $0.00 | ||
| $4.25M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $46.38M | ||
| $51.41M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| -$648.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$39.04M | ||
| $0.00 | ||
| $9.43M | ||
| Capex | $0.00 | |
| -$39.04M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| Jones Trading | → |
Analyst sentiment
Institutional ownership
Screeners with AVXL
Data Sources & References
- AVXL Official Website www.anavex.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1314052/000173112225001596/0001731122-25-001596-index.htm
- AVXL Profile on Yahoo Finance finance.yahoo.com/quote/AVXL
- AVXL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avxl
FAQ
What is the ticker symbol for Anavex Life Sciences Corp.?
The ticker symbol for Anavex Life Sciences Corp. is NASDAQ:AVXL
Does Anavex Life Sciences Corp. pay dividends?
No, Anavex Life Sciences Corp. does not pay dividends
What sector is Anavex Life Sciences Corp. in?
Anavex Life Sciences Corp. is in the Healthcare sector
What industry is Anavex Life Sciences Corp. in?
Anavex Life Sciences Corp. is in the Biotechnology industry
What country is Anavex Life Sciences Corp. based in?
Anavex Life Sciences Corp. is headquartered in United States
When did Anavex Life Sciences Corp. go public?
Anavex Life Sciences Corp. initial public offering (IPO) was on August 2, 2006
Is Anavex Life Sciences Corp. in the S&P 500?
No, Anavex Life Sciences Corp. is not included in the S&P 500 index
Is Anavex Life Sciences Corp. in the NASDAQ 100?
No, Anavex Life Sciences Corp. is not included in the NASDAQ 100 index
Is Anavex Life Sciences Corp. in the Dow Jones?
No, Anavex Life Sciences Corp. is not included in the Dow Jones index
When was Anavex Life Sciences Corp. last earnings report?
Anavex Life Sciences Corp.'s most recent earnings report was on November 25, 2025
When does Anavex Life Sciences Corp. report earnings?
The next expected earnings date for Anavex Life Sciences Corp. is February 9, 2026